- Home
- SEER vs RENB Comparison
SEER vs RENB Comparison
Compare SEER & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- RENB
- Stock Information
- Founded
- SEER 2017
- RENB 2011
- Country
- SEER United States
- RENB United States
- Employees
- SEER N/A
- RENB N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- SEER Health Care
- RENB Health Care
- Exchange
- SEER Nasdaq
- RENB Nasdaq
- Market Cap
- SEER 105.0M
- RENB 113.1M
- IPO Year
- SEER 2020
- RENB N/A
- Fundamental
- Price
- SEER $1.77
- RENB $0.54
- Analyst Decision
- SEER Hold
- RENB
- Analyst Count
- SEER 1
- RENB 0
- Target Price
- SEER $3.00
- RENB N/A
- AVG Volume (30 Days)
- SEER 306.8K
- RENB 289.3K
- Earning Date
- SEER 11-05-2024
- RENB 11-12-2024
- Dividend Yield
- SEER N/A
- RENB N/A
- EPS Growth
- SEER N/A
- RENB N/A
- EPS
- SEER N/A
- RENB N/A
- Revenue
- SEER $14,738,000.00
- RENB N/A
- Revenue This Year
- SEER N/A
- RENB N/A
- Revenue Next Year
- SEER $43.19
- RENB N/A
- P/E Ratio
- SEER N/A
- RENB N/A
- Revenue Growth
- SEER N/A
- RENB N/A
- 52 Week Low
- SEER $1.46
- RENB $0.42
- 52 Week High
- SEER $2.48
- RENB $5.25
- Technical
- Relative Strength Index (RSI)
- SEER 59.85
- RENB 38.01
- Support Level
- SEER $1.65
- RENB $0.56
- Resistance Level
- SEER $1.75
- RENB $0.69
- Average True Range (ATR)
- SEER 0.06
- RENB 0.10
- MACD
- SEER 0.02
- RENB 0.01
- Stochastic Oscillator
- SEER 83.90
- RENB 13.57
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.